[Expert consensus statement on Pudilan Xiaoyan Oral Liquid in clinical practice]

Area of Science:

• Traditional Chinese Medicine
• Pharmacology
• Clinical Practice

Background:

• Pudilan Xiaoyan Oral Liquid is a recognized traditional Chinese medicine for treating pharyngitis and tonsillitis.
• It is listed in the Chinese Pharmacopoeia and various provincial health insurance directories.
• The drug has been recommended for H1N1 and Hand, Foot, and Mouth Disease (HFMD) prevention and treatment.

Purpose of the Study:

• To enhance clinician understanding of Pudilan Xiaoyan Oral Liquid.
• To provide evidence-based recommendations for its rational clinical application.
• To compile an expert consensus on the drug's use.

Main Methods:

• A nominal group method was employed.
• Front-line clinical experts from respiratory, infectious disease, and dermatology departments were involved.
• Clinical evidence and expert experience were synthesized.

Main Results:

• The consensus provides recommendations for clinical problems with and without direct evidence support.
• It addresses the relief of swelling and pain associated with heat and toxin accumulation.
• The consensus offers guidance based on integrated clinical research and expert experience.

Conclusions:

• This expert consensus serves as a preliminary reference for the clinical use of Pudilan Xiaoyan Oral Liquid.
• It aims to improve the understanding and application of this traditional Chinese medicine.
• The consensus supports evidence-based and experience-driven therapeutic strategies.